UnitedHealth Group Incorporated (NYSE:UNH) Stock Position Boosted by CHICAGO TRUST Co NA

CHICAGO TRUST Co NA raised its stake in UnitedHealth Group Incorporated (NYSE:UNHGet Rating) by 1.5% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 13,512 shares of the healthcare conglomerate’s stock after purchasing an additional 198 shares during the period. UnitedHealth Group accounts for approximately 1.6% of CHICAGO TRUST Co NA’s investment portfolio, making the stock its 8th largest holding. CHICAGO TRUST Co NA’s holdings in UnitedHealth Group were worth $6,386,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in UNH. Moneta Group Investment Advisors LLC grew its stake in shares of UnitedHealth Group by 100,076.4% during the fourth quarter. Moneta Group Investment Advisors LLC now owns 11,823,820 shares of the healthcare conglomerate’s stock worth $6,268,753,000 after acquiring an additional 11,812,017 shares during the last quarter. Norges Bank purchased a new stake in shares of UnitedHealth Group during the fourth quarter worth about $5,210,004,000. Arrowstreet Capital Limited Partnership grew its stake in shares of UnitedHealth Group by 1,682.4% during the first quarter. Arrowstreet Capital Limited Partnership now owns 2,691,542 shares of the healthcare conglomerate’s stock worth $1,372,606,000 after acquiring an additional 2,540,538 shares during the last quarter. Morgan Stanley lifted its holdings in shares of UnitedHealth Group by 13.8% during the fourth quarter. Morgan Stanley now owns 15,635,038 shares of the healthcare conglomerate’s stock worth $8,289,386,000 after purchasing an additional 1,893,192 shares during the period. Finally, Vanguard Group Inc. lifted its holdings in shares of UnitedHealth Group by 1.0% during the third quarter. Vanguard Group Inc. now owns 82,969,869 shares of the healthcare conglomerate’s stock worth $41,903,103,000 after purchasing an additional 851,994 shares during the period. Hedge funds and other institutional investors own 92.61% of the company’s stock.

Insider Buying and Selling at UnitedHealth Group

In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,684 shares of the company’s stock in a transaction on Monday, April 24th. The stock was sold at an average price of $488.46, for a total value of $822,566.64. Following the completion of the sale, the executive vice president now directly owns 8,675 shares in the company, valued at approximately $4,237,390.50. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. In other news, CEO Andrew Witty sold 6,160 shares of the company’s stock in a transaction on Thursday, April 27th. The stock was sold at an average price of $487.49, for a total value of $3,002,938.40. Following the transaction, the chief executive officer now owns 86,564 shares of the company’s stock, valued at approximately $42,199,084.36. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, EVP Erin Mcsweeney sold 1,684 shares of the company’s stock in a transaction on Monday, April 24th. The shares were sold at an average price of $488.46, for a total value of $822,566.64. Following the completion of the transaction, the executive vice president now directly owns 8,675 shares in the company, valued at approximately $4,237,390.50. The disclosure for this sale can be found here. Insiders sold a total of 8,852 shares of company stock worth $4,313,962 in the last three months. 0.35% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

UNH has been the subject of a number of research reports. Royal Bank of Canada reaffirmed an “outperform” rating and set a $592.00 target price on shares of UnitedHealth Group in a report on Monday, April 17th. JPMorgan Chase & Co. decreased their target price on UnitedHealth Group from $595.00 to $562.00 in a report on Tuesday, May 30th. Oppenheimer reaffirmed an “outperform” rating and set a $610.00 target price on shares of UnitedHealth Group in a report on Monday, April 17th. TD Cowen decreased their price target on UnitedHealth Group from $596.00 to $562.00 and set an “outperform” rating for the company in a report on Monday, April 17th. Finally, Stephens reissued an “overweight” rating and issued a $605.00 price target on shares of UnitedHealth Group in a report on Tuesday, February 28th. One research analyst has rated the stock with a hold rating, fourteen have given a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Buy” and an average target price of $592.68.

UnitedHealth Group Stock Up 1.6 %

Shares of UNH opened at $476.76 on Thursday. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.81 and a current ratio of 0.81. UnitedHealth Group Incorporated has a one year low of $445.68 and a one year high of $558.10. The stock has a market capitalization of $443.88 billion, a price-to-earnings ratio of 21.80, a PEG ratio of 1.34 and a beta of 0.68. The stock has a 50 day moving average price of $486.82 and a 200 day moving average price of $493.14.

UnitedHealth Group (NYSE:UNHGet Rating) last issued its quarterly earnings results on Friday, April 14th. The healthcare conglomerate reported $6.26 EPS for the quarter, topping the consensus estimate of $6.24 by $0.02. UnitedHealth Group had a return on equity of 27.05% and a net margin of 6.16%. The firm had revenue of $91.93 billion during the quarter, compared to analysts’ expectations of $89.77 billion. During the same period in the previous year, the business earned $5.49 earnings per share. The firm’s revenue for the quarter was up 14.7% on a year-over-year basis. Equities research analysts forecast that UnitedHealth Group Incorporated will post 24.86 earnings per share for the current fiscal year.

UnitedHealth Group Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, June 27th. Shareholders of record on Monday, June 19th will be issued a $1.88 dividend. This is a boost from UnitedHealth Group’s previous quarterly dividend of $1.65. This represents a $7.52 annualized dividend and a yield of 1.58%. The ex-dividend date of this dividend is Thursday, June 15th. UnitedHealth Group’s dividend payout ratio is presently 34.39%.

About UnitedHealth Group

(Get Rating)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Featured Stories

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHGet Rating).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.